L. Ehlers

2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis

W. Dixon, E. Matteson, F. Buttgereit, 2018, Annals of the rheumatic diseases.

Age-related increase of mitochondrial content in human memory CD4+ T cells contributes to ROS-mediated increased expression of proinflammatory cytokines

P. Hoff, T. Gaber, F. Buttgereit, 2022, Frontiers in Immunology.

The Anti-Glucocorticoid Receptor Antibody Clone 5E4: Raising Awareness of Unspecific Antibody Binding

P. Mertins, T. Gaber, C. Strehl, 2022, International journal of molecular sciences.

Metabolic reprogramming of synovial fibroblasts in osteoarthritis by inhibition of pathologically overexpressed pyruvate dehydrogenase kinases.

T. Gaber, F. Buttgereit, Marieluise Kirchner, 2022, Metabolic engineering.

Glucocorticoids—All-Rounders Tackling the Versatile Players of the Immune System

T. Gaber, C. Strehl, F. Buttgereit, 2019, Front. Immunol..

Surface AMP deaminase 2 as a novel regulator modifying extracellular adenine nucleotide metabolism

T. Gaber, C. Strehl, F. Buttgereit, 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

E. Matteson, F. Buttgereit, J. Smolen, 2023, Annals of the Rheumatic Diseases.

OPA1 is Basis for Macrophages, Glucocorticoids Subunits, Neutrophile, RAW264.7 Cells and T-Cells Regulations, where OPA1 Contain COX Sequence Followed by Synthetase, then Synthase, then Phospholipase Sequences Respectively

C. Strehl, L. Ehlers, 2021, International Journal on Pharmacy and Sciences.

Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review

F. Buttgereit, D. Aletaha, A. Kerschbaumer, 2023, Rheumatology.